This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Clinical data | |
---|---|
Trade names | RLF-100 / Zyesamiô |
AHFS/Drugs.com | International Drug Names |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C147H237N43O43S |
Molar mass | 3326.83 g·mol−1 |
3D model (JSmol) |
|
SMILES
| |
InChI
| |
(what is this?) (verify) |
Aviptadil is an injectable synthetic formulation of human vasoactive intestinal peptide (VIP).[1] VIP was discovered in 1970, and has been used to treat various inflammatory conditions, such as acute respiratory distress syndrome (ARDS), asthma, and chronic obstructive pulmonary disease (COPD).